A short review on antibody therapy for COVID-19

The beginning of the novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). By April 07, 2020, SARS-CoV-2 has affected more than 1.36 million people worldwide and caused more than 75,900 deaths. To date, the anti-malaria drug hydroxychl...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkat Kumar, G., Jeyanthi, V., Ramakrishnan, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167584/
https://www.ncbi.nlm.nih.gov/pubmed/32313660
http://dx.doi.org/10.1016/j.nmni.2020.100682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167584/
https://www.ncbi.nlm.nih.gov/pubmed/32313660
http://dx.doi.org/10.1016/j.nmni.2020.100682

Ejemplares similares